乏氧组织显像剂及其应用
-
摘要: 简述了乏氧组织显像剂的发展过程,阐明了乏氧组织显像在临床诊断中的重要性以及显像原理,指出理想的乏氧组织显像剂应具备的条件,详细探讨了乏氧组织显像药物的研究和应用,描述了99mTc标记的乏氧组织显像剂的应用前景。
-
[1] Nunn A et al. Eur J Nucl Med,1995;22(3):265 [2] Patterson RE et al. J Nucl Med,1995;36:1086 [3] Archer CM et al. J Ncul Biol Med,1994;38(3):473 [4] Schneider RF et al. Quarterly J Nucl Med,1995;39(1):41 [5] Edwards DI. J Antimicrob Chemother,1993;31:9 [6] Groshar D et al. J Nucl Med,1993;34:885 [7] Al-Arafaj A et al. Eur J Nucl Med,1994;21:1338 [8] Yeh SH et al. J Nucl Med,1994;35:205P(abs) [9] Grunbaum Z et al. J Nucl Med,1987;28:68 [10] Jerabeck PA et al. Int J Radiat Appl Instrum[A],1986;37:599 [11] Rasey JS et al. Radiat Res,1987;111:292 [12] Biskupiak JE et al. J Med Chem,1991;34:2165 [13] Wiebe LI et al. Nuklearmedizin,1984;23:63 [14] Linder KE et al. J Med Chem,1994;37:9 [15] Mannan RH et al. J Nucl Med,1991;32:1764 [16] Linker KE et al. Bioconj Chem,1993;4:326 [17] Raju N et al. Tetrahedron,1993;48:10233 [18] Predegas JL et al. Biochem Pharmacol,1991;42:2387 [19] Linder KE et al. J Nucl Med,1994;35:18P(abs) [20] Rumsey WL et al. Potential of nitroimidazoleas markers of hypoxia in heart. In:Vaupel Pet al,eds. Oxygen transport to tissue. NewYork:Plenum;1994:263-270 [21] Di Rocco RJ et al. J Cereb Blood Flow Metab,1993;13:755 [22] Chan YW et al. J Nucl Med,1994;35:152 P(abs) [23] World Patent Appl. WO94089-A1,Amersham Int. plc [24] Linder KE et al. J Labelled Compd Radiopharm,1995;37:202 [25] Stone CK et al. J Nucl Med,1995;36(5):138P(abs) [26] Ramalingam K et al. J Nucl Med,1994;35(5):260 P (abs) [27] Zhang Z et al. J Labelled Compd Radiopharm,1995;37:205 [28] Zhang Z et al. J Nucl Med,1994;38:472 [29] Okada RD et al. Eur J Nucl Med,1996;23:443 [30] Kuczynski B et al. J Nucl Cardio,1995;4:S28(abs)
点击查看大图
计量
- 文章访问数: 1121
- HTML全文浏览量: 245
- PDF下载量: 2